Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128518) titled 'To evaluate the efficacy and safety of 1064 nm picosecond laser combined with 1565 nm non-ablative fractional laser for the treatment of periorbital rejuvenation' on July 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xi'an International Medical Center Hospital
Condition:
Periorbital aging is characterized by multi-layered degenerative alterations, including deepening rhytides, hyperpigmentation (periorbital hyperpigmentation), rough texture, loss of elasticity, and ptosis, and represents the earliest facial region to exhibit aging stigmata. Given the distinctive anatomical featu...